(please send us a short message outlining why you interested in applying for the job, including salary expectations)

    CANCEL

    Day 2, 17 November 2022 (Thursday)

    Please register here for all 3-day Annual Conference

    Day 2, 17 November 2022 (Thursday)

    Please register here for all 3-day Annual Conference

    Dr. Leo Braack, Senior Vector Control Specialist, Malaria Consortium

    Leo is a medical entomologist, having spent most of his life in Africa. He moved to Asia in early 2019 where he now works for Malaria Consortium as Senior Vector Control Specialist, supporting malaria and dengue vector control projects in mainly Cambodia and Myanmar. He is also Co-Chair and Technical Lead for the Asia Pacific Malaria Elimination Network (APMEN) Vector Control Working Group (VCWG), and through that platform supports the development and implementation of various vector control capacity-building interventions for NMCP’s and other institutions in Asia Pacific. Leo believes that as malaria recedes in impact and importance in Asia in the decade ahead, dengue is going to emerge as a serious public health threat which deserves early attention.

    1:00 pm - 1:10 pm ( UTC )

    Introduction: Summary overview of findings of Day 1, and objectives for Day 2

    Dr Chantana Padungtod, Director of Division of Vector Borne Diseases, Department of Disease Control, Ministry of Public Health, Thailand
    1:10 pm - 1:20 pm ( UTC )

    Short meeting-opening address from Thailand Vector-borne disease control Director

    Amir Galili, CEO Westham Co

    Amir founded Westham in 2006 and currently serves as CEO. Prior to founding Westham, Amir was the founder and CEO of Trivnet, a micro-payment technology company. Amir has significant experience in product research and development. Amir holds a B.S. in Electrical Engineering and an M.B.A. from Tel Aviv University. 

    1:20 pm - 12:00 am ( UTC )

    Attractive Targeted Sugar Baits (ATSBs)

    Dr Din Syafruddin, Professor, Department of Parasitology, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia

    He was trained in medicine and doctoral degree in the parasite cell biology, he is currently a senior research fellow at the Malaria and Vector Resistance Laboratory at the Eijkman Institute for Molecular Biology, Jakarta and Professor and chairman of the Department of Parasitology, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia.  He joined the Eijkman Institute in 1993 as a post doctoral research fellow and was involved in a research project to elucidate the role of the extrachromosomal DNAs in the assembly of the mitochondrial energy transducing membrane of the malarial parasite.  His current research activities include molecular mechanisms underlying Plasmodium resistance to antimalarial drug, antimalarial drug discovery, molecular taxonomy of the mosquito vector and the molecular studies on the vector resistance to insecticides. 

    1:35 pm - 1:50 pm ( UTC )

    Impact of a spatial repellent product on Anopheles and non-Anopheles mosquitoes in Sumba, Indonesia

    Victor Chaumeau, SMRU Entomology Lab Supervisor

    Victor leads the Entomology Laboratory at the SMRU. He is conducting operational research on the entomological aspects of malaria elimination in Kayin state, Myanmar. The aims of this work are

    •document the bionomics of the local mosquito vectors,

    •demonstrate the interruption of malaria transmission in the area targeted by the program 

    •develop adequate vector-control interventions and strategies.

    Future research axis will involve specific studies on the assessment of mosquito bed-nets efficacy, on the serological markers of exposure to mosquito bites and on insecticide resistances. Victor also leaded collaborative efforts to set-up a platform to study Plasmodium vivax hypnozoites in vitro. Major achievements of this platform include the production of high numbers of sporozoites using laboratory-adapted mosquito colonies artificially infected with clinical blood specimens from patients infected with P. vivax, the development of two different hepatocyte culture systems that support the development of P. vivax liver stages and the screening of dozens of thousands of compounds for their activity against dormant hypnozoites. In addition of the screening component, future studies will focus on the biology of the hypnozoite. The aims of this research are to identify new antimalarial drugs to be used for the radical cure of vivax malaria and to improve the understanding of the epidemiology of this neglected disease.

    1:50 pm - 2:05 pm ( UTC )

    Targeted outdoor residual spraying

    Dr Kevin Kobylinski, Medical Entomologist, Armed Forces Research Institute of Medical Sciences, Department of Entomology

    Dr Kevin Kobylinski is a Medical Entomologist based at the Armed Forces Research Institute of Medical Sciences, Department of Entomology. He has a PhD in Microbiology from Colorado State University and an MS in Medical Entomology from the University of Florida. He has spent the last several years developing the concept of ivermectin mass drug administration for malaria parasite transmission suppression, with keen interest on integration of malaria and neglected tropical disease control efforts. During his PhD he demonstrated the impact of ivermectin mass drug administration on malaria transmission in Southeastern Senegal. He has characterized the ivermectin susceptibility and sporontocidal impact on important Anopheles from the Greater Mekong Subregion, Africa, and South America in laboratory studies and clinical trials, and is collaborating with Mahidol University to evaluate the impact of ivermectin mass drug administration on Plasmodium transmission in Southern Thailand.

    2:05 pm - 2:20 pm ( UTC )

    Endectocides for malaria control

    Pongsakorn Sadakorn, Public Health Technical Officer, Division of Vector Borne Diseases, Department of Disease Control, Ministry of Public Health, Thailand
    2:20 pm - 2:30 pm ( UTC )

    Malaria situation and vector-borne disease control challenge in Thailand

    2:20 pm - 2:30 pm ( UTC )

    5-min break

    2:30 pm - 3:00 pm ( UTC )

    Q&A Session

    3:00 pm - 3:05 pm ( UTC )

    Explanation and preparation before Break-out group session

    3:05 pm - 3:35 pm ( UTC )

    Break-out group discussion on research and implementation needs for outdoor transmission reduction (including regulatory needs)

    3:35 pm - 3:50 pm ( UTC )

    Plenary feedback

    Dr. Leo Braack, Senior Vector Control Specialist, Malaria Consortium

    Leo is a medical entomologist, having spent most of his life in Africa. He moved to Asia in early 2019 where he now works for Malaria Consortium as Senior Vector Control Specialist, supporting malaria and dengue vector control projects in mainly Cambodia and Myanmar. He is also Co-Chair and Technical Lead for the Asia Pacific Malaria Elimination Network (APMEN) Vector Control Working Group (VCWG), and through that platform supports the development and implementation of various vector control capacity-building interventions for NMCP’s and other institutions in Asia Pacific. Leo believes that as malaria recedes in impact and importance in Asia in the decade ahead, dengue is going to emerge as a serious public health threat which deserves early attention.

    3:50 pm - 4:00 pm ( UTC )

    Closing Day 2